| Mar 06 | Mar 05 | Mar 04 | Mar 03 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | ||||
| Gross Profit | $ 173.98K | $ 334.65K | $ 113.62K | - |
| Operating Income | $ -5.34M | $ -3.74M | $ -7.06M | $ -7.52M |
| EBITDA | $ -5.34M | $ -3.74M | $ -7.06M | $ -7.52M |
| Net Income | $ -5.45M | $ -3.84M | $ -7.29M | $ -7.05M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 153.39K | $ 269.36K | $ 119.30K | $ 3.24K |
| Total Debt | $ 851.67K | $ 1.11M | $ 2.43M | $ 1.65M |
| Net Debt | $ 830.42K | $ 1.06M | $ 2.41M | $ 1.65M |
| Total Liabilities | $ 3.12M | $ 2.94M | $ 3.18M | $ 2.70M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | ||||
| Free Cash Flow | $ -230.84K | $ -130.32K | $ -677.16K | $ -2.93M |
| Operating Cash Flow | $ -230.84K | $ -130.32K | $ -677.16K | $ -2.93M |
| Investing Cash Flow | ||||
| Financing Cash Flow |
US Global Nanospace Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.